Toggle navigation
About
Our People
Scientific Advisory Board
Partners and Distributors
Corporate Directory
Corporate Governance
COVID-19: Information for People Using Bronchitol
Product Pipeline
Drug Discovery
Amine Oxidase Platform
Oral pan-LOX Inhibitor (PXS-5505)
Topical pan-LOX Inhibitor (PXS-6302)
SSAO Inhibitor (PXS-4728)
LOXL2 Inhibitors (PXS-5382)
Other Amine Oxidase Inhibitor Programs
Other Pipeline Assets
Orbital® Dry Powder Inhaler
Publications & Posters
Patents
Approved Products
Manufacturing Facilities
Bronchitol®
Cystic Fibrosis
Clinical Trials
Publications
Patents
Partners and Distributors
COVID-19: Information for People Using Bronchitol
Aridol®
Asthma
Clinical Trials
Publications
Patents
Distributors
News
Patients & Prescribers
Contact
Media
Follow us
Investor Centre
Investor Centre
News
ASX Announcements
Quarterly Updates
Annual and Half Year Reports
Investor Presentations
Shareholder Services
Upcoming Events
Analyst Coverage
Major Shareholders
Corporate Governance
Subscribe to our emails or follow us
Videos and Podcasts
Investor Centre
Quarterly Updates
Quarterly Updates
Quarterly Updates
Skip to
January
April
July
October
2023
6th
Feb 04
Quarterly Report to Shareholders - December 2003
Read quarterly update - pdf
‹
Prev
1
…
23
24
25
26
27
Archives
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
